These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16312722)

  • 1. Our experiences in visceral leishmaniasis therapy.
    Titone L; Scarlata F; Cascio A; Giordano S; Mancuso G
    J Chemother; 1989 Jul; 1(4 Suppl):960-1. PubMed ID: 16312722
    [No Abstract]   [Full Text] [Related]  

  • 2. Pediatric visceral leishmaniasis in Western Sicily, Italy: a retrospective analysis of 111 cases.
    Cascio A; Colomba C; Antinori S; Orobello M; Paterson D; Titone L
    Eur J Clin Microbiol Infect Dis; 2002 Apr; 21(4):277-82. PubMed ID: 12072938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visceral leishmaniasis treatment, Italy.
    Gradoni L; Gramiccia M; Scalone A
    Emerg Infect Dis; 2003 Dec; 9(12):1617-20. PubMed ID: 14720406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [N-methyl glucamine antimoniate or Glucantime].
    Rapp C; Simon F; Dordain ML
    Med Trop (Mars); 2000; 60(4):342-3. PubMed ID: 11436584
    [No Abstract]   [Full Text] [Related]  

  • 5. [Canine leishmaniasis in Spain: data for the clinician].
    Ferrer L
    Enferm Infecc Microbiol Clin; 1989; 7(6):293-5. PubMed ID: 2490443
    [No Abstract]   [Full Text] [Related]  

  • 6. Low dosage combination of meglumine antimoniate plus allopurinol as first choice treatment of infantile visceral leishmaniasis in Italy.
    di Martino L; Mantovani MP; Gradoni L; Gramiccia M; Guandalini S
    Trans R Soc Trop Med Hyg; 1990; 84(4):534-5. PubMed ID: 2091347
    [No Abstract]   [Full Text] [Related]  

  • 7. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
    Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N
    Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mediterranean visceral leishmaniasis in pregnancy.
    Gradoni L; Gaeta GB; Pellizzer G; Maisto A; Scalone A
    Scand J Infect Dis; 1994; 26(5):627-9. PubMed ID: 7855563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of visceral leishmaniasis.
    Ozsoylu S
    Am J Dis Child; 1992 Sep; 146(9):1021. PubMed ID: 1514542
    [No Abstract]   [Full Text] [Related]  

  • 10. [Kala-azar. Apropos of a case report in a Belgian woman].
    Coutellier P; Delgrange B
    Acta Clin Belg; 1989; 44(5):362-3. PubMed ID: 2609847
    [No Abstract]   [Full Text] [Related]  

  • 11. A case report of Kala-Azar in a kidney transplant patient.
    Malek Hosseini SA; Javid R; Salahi H; Nezakatgoo N; Ahmad E; Ghahramani N
    Transplant Proc; 1995 Oct; 27(5):2715. PubMed ID: 7482886
    [No Abstract]   [Full Text] [Related]  

  • 12. [Visceral leishmaniasis with benign course in a patient infected with human immunodeficiency virus].
    Ribelles N; Casals A; Vallés J; Clotet B
    Med Clin (Barc); 1989 May; 92(17):679. PubMed ID: 2747338
    [No Abstract]   [Full Text] [Related]  

  • 13. [Visceral leishmaniasis in immunocompetent adult with severe sepsis].
    Ezzouine H; Charra B; Benslama A; Motaouakkil S
    Ann Fr Anesth Reanim; 2010 Mar; 29(3):255-6. PubMed ID: 20227234
    [No Abstract]   [Full Text] [Related]  

  • 14. [Acute pancreatitis during treatment with meglumine antimoniate (Glucantime)].
    Barthet M; Brunet P; Bernard JC; Dussol B; Rodor F; Jouglard J; Berland Y; Sahel J
    Gastroenterol Clin Biol; 1994; 18(1):90-2. PubMed ID: 8187998
    [No Abstract]   [Full Text] [Related]  

  • 15. [Association of acute lymphoblastic leukaemia and visceral leishmaniasis].
    Nafil H; Tazi I; Mahmal L
    Ann Biol Clin (Paris); 2011; 69(6):729-31. PubMed ID: 22123576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of paediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds?
    Kafetzis DA; Velissariou IM; Stabouli S; Mavrikou M; Delis D; Liapi G
    Int J Antimicrob Agents; 2005 Jan; 25(1):26-30. PubMed ID: 15620822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of Leishmania tropica from a patient with visceral leishmaniasis and disseminated cutaneous leishmaniasis, southern Iran.
    Alborzi A; Pouladfar GR; Fakhar M; Motazedian MH; Hatam GR; Kadivar MR
    Am J Trop Med Hyg; 2008 Sep; 79(3):435-7. PubMed ID: 18784238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meglumine antimoniate-induced pancreatitis.
    Torrús D; Massa B; Boix V; Portilla J; Pérez-Mateo M
    Am J Gastroenterol; 1996 Apr; 91(4):820-1. PubMed ID: 8677970
    [No Abstract]   [Full Text] [Related]  

  • 19. Glucantime-resistant visceral leishmaniasis in immunocompromised patients.
    Verdejo J; Alvar J; Polo RM; González-Lahoz JM
    Am J Med; 1988 Jul; 85(1):128. PubMed ID: 3389377
    [No Abstract]   [Full Text] [Related]  

  • 20. Short report: Contribution of quantitative real-time polymerase chain reaction to follow-up of visceral leishmaniasis patients treated with meglumine antimoniate.
    Aoun K; Chouihi E; Amri F; Ben Alaya N; Raies A; Mary C; Bouratbine A
    Am J Trop Med Hyg; 2009 Dec; 81(6):1004-6. PubMed ID: 19996428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.